© Journal of Thoracic Disease. All rights reserved. J Thorac Dis 2019; 11 (Suppl 9): S1420-
S1422| http://dx. doi. org/10.21037/jtd. 2019.02. 94 20% and 57% of the PM and SBRT …

Simple Summary Stereotactic body radiation therapy (SBRT) is currently used to treat lung
metastasis, particularly in the setting of oligometastatic disease. Objective of this treatment is …

Purpose We report the retrospective data of a cohort of patients who received stereotactic
body radiotherapy for pulmonary oligometastases, aiming to assess the clinical factors …

To analyze the impact of SBRT on systemic treatment-free survival in patients affected by
lung oligometastases. Inclusion criteria of the study were (a) KPS> 70,(b) 1–5 lung …

Purpose To assess the clinical results in terms of local control, toxicity, failure pattern and
toxicity of SBRT in oligometastatic patients with inoperable lung metastases. Methods Forty …

Background and purpose Stereotactic ablative radiotherapy (SABR; or stereotactic body
radiotherapy, SBRT) emerges as treatment option for pulmonary oligometastatic disease …

Background: Since the concept of oligometastases was proposed, several investigators
have suggested that aggressive local treatment of oligometastatic disease may be helpful in …

Background Data in the literature suggest the existence of oligometastatic disease, a state in
which metastases are limited in number and site. Different kinds of local therapies have …

Purpose Many technological and methodical advances have made stereotactic body
radiotherapy (SBRT) more accurate and more efficient during the last years. This study aims …

Background Stereotactic body radiotherapy (SBRT) for oligometastatic disease is
characterized by an excellent safety profile; however, experiences are mostly based on …